Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Teradata, Seritage, and Oddity Tech and Encourages Investors to Contact the Firm
July 27, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for CAE, AAL, and ODD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
July 26, 2024 12:13 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, July 26, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Oddity Tech Ltd. to Secure Counsel Before Important Deadline in Securities Class Action - ODD
July 25, 2024 16:09 ET
|
The Rosen Law Firm PA
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of...
ODD Investors Have Opportunity to Lead Oddity Tech Ltd. Securities Fraud Lawsuit with the Schall Law Firm
July 24, 2024 12:50 ET
|
Schall Law
ODD Investors Have Opportunity to Lead Oddity Tech Ltd. Securities Fraud Lawsuit with the Schall Law Firm
From high tech to high impact: Sidetrade's journey to a more sustainable world
July 24, 2024 12:03 ET
|
Sidetrade
Sidetrade, the global leader in AI-powered Order-to-Cash applications, releases its 2023 Corporate Social Responsibility (CSR) report today. This report marks Sidetrade’s significant progress in...
Le voyage de Sidetrade vers un monde plus durable
July 24, 2024 12:03 ET
|
Sidetrade
Sidetrade, plateforme d’intelligence artificielle (IA) dédiée à la sécurisation et à la génération du cashflow des entreprises, publie aujourd'hui son rapport sur la responsabilité sociétale des...
ODDITY TECH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Oddity Tech and Encourages Investors to Contact the Firm
July 23, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Oddity...
ODDITY TECH LTD. (NASDAQ: ODD) INVESTOR ALERT: Investors With Large Losses in Oddity Tech Ltd. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
July 22, 2024 15:48 ET
|
Bernstein Liebhard LLP
ODDITY TECH LTD. (NASDAQ: ODD) INVESTOR ALERT: Investors With Large Losses in Oddity Tech Ltd. Should Contact Bernstein Liebhard To Discuss Their Rights
ODDITY TECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Oddity Tech on Behalf of Oddity Tech Stockholders and Encourages Investors to Contact the Firm
May 24, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Oddity Tech (“Oddity Tech”...
The United States FDA Awards Orphan Drug Designation (ODD) to NM5072 for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)
April 15, 2024 08:30 ET
|
NovelMed Therapeutics Inc
The United States Food and Drug Administration (FDA) has awarded orphan drug designation (ODD) to NM5072 for the treatment of anemia in PNH patients.The ODD provides NM5072 with a range of benefits,...